Showing results (831-840 of 2,003) with videos related to
Sort By:
Pageof 201
Endocrine, Metabolic & Immune Disorders Drug Targets|October 5, 2016
Morphometrical and Morphological Alterations of Human Leukocytes Exposed to 1.8 GHz Electromagnetic Radiations: In Vitro Protective Effects Induced by PolyphenolsPier Francesco Biagi, Sara Boffola, Riccardo Stefanelli, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|October 5, 2016
Cigarette Smoke-mediated Perturbations of the Immune Response: A New Therapeutic Approach with Natural CompoundsThea Magrone, Matteo Antonio Russo, Emilio JirilloEndocrine, Metabolic & Immune Disorders Drug Targets|April 30, 2015
Actions of Adjunctive Nutritional Antioxidants in Periodontitis and Prevalent Systemic Inflammatory DiseasesU El-Shinnawi, M SooryEndocrine, Metabolic & Immune Disorders Drug Targets|May 7, 2015
Use Of External Intrathecal Infusion Pumps In The Management Of Septic Complications: A Case ReportRiccardo Marvulli, Pierpaolo Chiumarulo, Mattia Nisi, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|May 26, 2015
Drug Targeting Based on a New Concept-Targeting Against TLR4 as an ExampleYoshiro Maru, Takeshi Tomita, Atsuko Deguchi, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|March 10, 2023
Anxiety, Depression, Body Mass Index, Physical Activity in Nomophobic Italian Nurses: A Chronic Latent Inflammation?Elsa Vitale, Rocco Mea, Angelo Benedetto, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|March 15, 2023
WITHDRAWN: Evaluation and Association of Hematological and Biochemical Parameters of Untreated COVID-19 Patients on the basis of Differences in Ethnicity and Curcumin as a Possible TreatmentMunir Akhtar, Rubaida Mehmood, Mukhtar Hussain, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|November 14, 2022
Role of HLA-DPrs3077 and HLA-DQrs3920 Polymorphisms as Risk Factors for Type 1 Diabetes MellitusAmany A GhazyEndocrine, Metabolic & Immune Disorders Drug Targets|August 25, 2025
Continuous Interstitial Glucose Monitoring through a Long-Term Subcutaneous Implantable Sensor during Pregnancy in Type 1 Diabetes: A Two- Patient Case ReportN Betella, V Resi, A Gaglio, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|August 28, 2025
Jiangtang Decoction for Type 2 Diabetes and NAFLD: Integrative Analysis via Network Pharmacology, Mendelian Randomization, Molecular Docking, and In Vitro ValidationWenbo Gong, Xueke Lu, Siying WengPageof 201